154 related articles for article (PubMed ID: 23642304)
1. Eosinophils affect functions of in vitro-activated human CD3-CD4+ T cells.
Harfi I; Schandené L; Dremier S; Roufosse F
J Transl Med; 2013 May; 11():112. PubMed ID: 23642304
[TBL] [Abstract][Full Text] [Related]
2. Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome.
Roufosse F; de Lavareille A; Schandené L; Cogan E; Georgelas A; Wagner L; Xi L; Raffeld M; Goldman M; Gleich GJ; Klion A
J Allergy Clin Immunol; 2010 Oct; 126(4):828-835.e3. PubMed ID: 20810155
[TBL] [Abstract][Full Text] [Related]
3. CD3
Carpentier C; Schandené L; Dewispelaere L; Heimann P; Cogan E; Roufosse F
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2426-2439.e7. PubMed ID: 33545400
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilia Associated With CD3
Carpentier C; Verbanck S; Schandené L; Heimann P; Trépant AL; Cogan E; Roufosse F
Front Immunol; 2020; 11():1765. PubMed ID: 32849632
[No Abstract] [Full Text] [Related]
5. The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype.
Lefèvre G; Copin MC; Staumont-Sallé D; Avenel-Audran M; Aubert H; Taieb A; Salles G; Maisonneuve H; Ghomari K; Ackerman F; Legrand F; Baruchel A; Launay D; Terriou L; Leclech C; Khouatra C; Morati-Hafsaoui C; Labalette M; Borie R; Cotton F; Gouellec NL; Morschhauser F; Trauet J; Roche-Lestienne C; Capron M; Hatron PY; Prin L; Kahn JE;
Medicine (Baltimore); 2014 Oct; 93(17):255-266. PubMed ID: 25398061
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways.
Ravoet M; Sibille C; Gu C; Libin M; Haibe-Kains B; Sotiriou C; Goldman M; Roufosse F; Willard-Gallo K
Blood; 2009 Oct; 114(14):2969-83. PubMed ID: 19608752
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclosporine on lymphocytic variant hypereosinophilic syndrome.
Tabata R; Tabata C; Katashima Y; Yasumizu R
Int Immunopharmacol; 2013 Aug; 16(4):488-91. PubMed ID: 23669338
[TBL] [Abstract][Full Text] [Related]
8. New diagnostic tool for differentiation of idiopathic hypereosinophilic syndrome (HES) and secondary eosinophilic states.
Berki T; Dávid M; Bóné B; Losonczy H; Vass J; Németh P
Pathol Oncol Res; 2001; 7(4):292-7. PubMed ID: 11882909
[TBL] [Abstract][Full Text] [Related]
9. The interleukin-5 messenger RNA expression in a patient with idiopathic hypereosinophilic syndrome.
Ho KK; Ho AS; Leung RC; Lai CK; Lai KN
Clin Exp Allergy; 1998 Jul; 28(7):889-92. PubMed ID: 9720824
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
11. A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5.
Brugnoni D; Airó P; Rossi G; Bettinardi A; Simon HU; Garza L; Tosoni C; Cattaneo R; Blaser K; Tucci A
Blood; 1996 Feb; 87(4):1416-22. PubMed ID: 8608231
[TBL] [Abstract][Full Text] [Related]
12. Current strategies in the management of hypereosinophilic syndrome, including mepolizumab.
Schwartz LB; Sheikh J; Singh A
Curr Med Res Opin; 2010 Aug; 26(8):1933-46. PubMed ID: 20565230
[TBL] [Abstract][Full Text] [Related]
13. IL-5-induced hypereosinophilia suppresses the antigen-induced immune response via a TGF-beta-dependent mechanism.
Nakagome K; Dohi M; Okunishi K; Tanaka R; Kouro T; Kano MR; Miyazono K; Miyazaki J; Takatsu K; Yamamoto K
J Immunol; 2007 Jul; 179(1):284-94. PubMed ID: 17579048
[TBL] [Abstract][Full Text] [Related]
14. Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells.
Davoine F; Cao M; Wu Y; Ajamian F; Ilarraza R; Kokaji AI; Moqbel R; Adamko DJ
J Allergy Clin Immunol; 2008 Jul; 122(1):69-77, 77.e1-2. PubMed ID: 18472150
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilia associated with clonal T-cell proliferation.
Kitano K; Ichikawa N; Shimodaira S; Ito T; Ishida F; Kiyosawa K
Leuk Lymphoma; 1997 Oct; 27(3-4):335-42. PubMed ID: 9402331
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling.
Smeets RL; Fleuren WW; He X; Vink PM; Wijnands F; Gorecka M; Klop H; Bauerschmidt S; Garritsen A; Koenen HJ; Joosten I; Boots AM; Alkema W
BMC Immunol; 2012 Mar; 13():12. PubMed ID: 22413885
[TBL] [Abstract][Full Text] [Related]
17. Local production of interleukin-5 by T lymphocytes is associated with recruitment of eosinophils in patients with eosinophilic granuloma of the soft tissue.
Yoshida M; Masuyama K; Ogata N; Samejima Y; Eura M; Ishikawa T
Int Arch Allergy Immunol; 1996 Oct; 111(2):133-41. PubMed ID: 8859221
[TBL] [Abstract][Full Text] [Related]
18. Relationship between interleukin-5 production and variations in eosinophil counts during HIV infection in West Africa: influence of Mycobacterium tuberculosis infection.
Diagbouga S; Aldebert D; Fumoux F; Capron M; Ledru E
Scand J Immunol; 1999 Feb; 49(2):203-9. PubMed ID: 10075026
[TBL] [Abstract][Full Text] [Related]
19. Selective priming of peripheral blood eosinophils in patients with idiopathic hypereosinophilic syndrome.
Lampinen M; Oberg G; Venge P; Carlson M
APMIS; 2006 Nov; 114(11):757-63. PubMed ID: 17078855
[TBL] [Abstract][Full Text] [Related]
20. T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice.
Garlisi CG; Falcone A; Kung TT; Stelts D; Pennline KJ; Beavis AJ; Smith SR; Egan RW; Umland SP
Clin Immunol Immunopathol; 1995 Apr; 75(1):75-83. PubMed ID: 7533686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
